Clinical Trial Update: Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating an oncolytic adenovirus in combination with a PD-1 inhibitor for non-muscle-invasive bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• PD-1 inhibitor
• oncolytic adenovirus (oncolytic adenovirus)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Bladder Cancer | Phase 2 | Status: UNKNOWN